Fagan Associates, Inc. Bristol Myers Squibb CO Transaction History

Fagan Associates, Inc.

  • $571 Million
  • Q3 2024

A detailed history of Fagan Associates, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fagan Associates, Inc. holds 5,727 shares of BMY stock, worth $330,791. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,727
Holding current value
$330,791
% of portfolio
0.05%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$39.66 - $51.75 $227,132 - $296,372
5,727 New
5,727 $296,000
Q4 2023

Feb 07, 2024
SELL
$48.48 - $57.85 $3,005 - $3,586
-62 Reduced 1.29%
4,727 $242,000
Q2 2023

Aug 08, 2023
SELL
$63.71 - $70.74 $4,778 - $5,305
-75 Reduced 1.54%
4,789 $306,000
Q4 2021

Feb 08, 2022
SELL
$53.63 - $62.52 $2.93 Million - $3.41 Million
-54,555 Reduced 91.81%
4,864 $303,000
Q3 2021

Nov 09, 2021
BUY
$59.17 - $69.31 $273,720 - $320,628
4,626 Added 8.44%
59,419 $3.52 Million
Q2 2021

Aug 06, 2021
BUY
$61.91 - $67.42 $28,478 - $31,013
460 Added 0.85%
54,793 $3.66 Million
Q1 2021

May 06, 2021
BUY
$59.34 - $66.74 $602,894 - $678,078
10,160 Added 23.0%
54,333 $3.43 Million
Q4 2020

Feb 08, 2021
BUY
$57.74 - $65.43 $22,287 - $25,255
386 Added 0.88%
44,173 $2.74 Million
Q3 2020

Nov 02, 2020
BUY
$57.43 - $63.64 $34,458 - $38,184
600 Added 1.39%
43,787 $2.64 Million
Q2 2020

Aug 05, 2020
BUY
$54.82 - $64.09 $752,733 - $880,019
13,731 Added 46.62%
43,187 $2.54 Million
Q1 2020

May 05, 2020
BUY
$46.4 - $67.43 $433,422 - $629,863
9,341 Added 46.44%
29,456 $1.64 Million
Q4 2019

Feb 07, 2020
BUY
$49.21 - $64.19 $633,086 - $825,804
12,865 Added 177.45%
20,115 $1.29 Million
Q3 2019

Nov 13, 2019
BUY
$42.77 - $50.71 $310,082 - $367,647
7,250 New
7,250 $368,000
Q2 2019

Jul 12, 2019
SELL
$44.62 - $49.34 $192,312 - $212,655
-4,310 Closed
0 $0
Q1 2019

May 01, 2019
SELL
$45.12 - $53.8 $3,609 - $4,304
-80 Reduced 1.82%
4,310 $206,000
Q4 2018

Feb 05, 2019
BUY
$48.76 - $63.23 $22,185 - $28,769
455 Added 11.56%
4,390 $228,000
Q3 2018

Nov 06, 2018
SELL
$55.19 - $62.25 $24,835 - $28,012
-450 Reduced 10.26%
3,935 $244,000
Q2 2018

Aug 06, 2018
SELL
$50.53 - $62.98 $135,673 - $169,101
-2,685 Reduced 37.98%
4,385 $243,000
Q1 2018

May 08, 2018
SELL
$59.92 - $68.98 $5,992 - $6,898
-100 Reduced 1.39%
7,070 $447,000
Q4 2017

Feb 09, 2018
SELL
$59.94 - $65.35 $43,456 - $47,378
-725 Reduced 9.18%
7,170 $439,000
Q2 2017

Aug 07, 2017
BUY
N/A
7,895
7,895 $440,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Fagan Associates, Inc. Portfolio

Follow Fagan Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fagan Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fagan Associates, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email